⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17633973 | 0.97 | — | — | |
| SCHEMBL20042237 | 0.78 | — | — | |
| SCHEMBL16111870 | 0.76 | CYP1A2 (0.32) | — | |
| SCHEMBL2289434 | 0.75 | — | — | |
| SCHEMBL23344384 | 0.73 | — | — | |
| SCHEMBL2290082 | 0.73 | — | — | |
| SCHEMBL15491584 | 0.73 | — | — | |
| SCHEMBL24943860 | 0.73 | — | — | |
| SCHEMBL18897782 | 0.73 | — | — | |
| SCHEMBL20002640 | 0.70 | TSHR (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11718602-B2 | EGFR inhibitors | BLUEPRINT MEDICINES CORPORATION (US) | 2023-08-08 | — | — | US | disclosed |